Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Wasunna Km"'
Publikováno v:
Annals of Tropical Medicine And Parasitology. 93:703-710
A prototype test kit being developed, by the World Health Organization (WHO), for the diagnosis of visceral leishmaniasis (VL) was evaluated in the Baringo district of Rift Valley province in Kenya. The screening of approximately 10 000 individuals f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e9a5c1bd0a486beac2b9150c51e097c
https://doi.org/10.1080/00034989957952
https://doi.org/10.1080/00034989957952
Publikováno v:
Annals of Tropical Medicine And Parasitology. 92:571-577
Leishmania donovani promastigotes were cultured in a protein-free medium for 3-5 days and the spent medium used to prepare antibody-detection ELISA plates. When the plates were used to test 29 Kenyan and 16 Nepalese patients with visceral leishmanias
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54faa2c803464cd20e7153b23feb111c
https://doi.org/10.1080/00034989859267
https://doi.org/10.1080/00034989859267
Autor:
Bhatt, KM, Wasunna, KM
Publikováno v:
East African Medical Journal; Vol 83, No 5 (2006)
Background: Although artesunate and mefloquine have been used as monotherapies in the treatment of malaria in Kenya for a long time, there is insufficient data on the clinical outcome when used as combination therapy in this population. Objective: To
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=78975075580c::13b842439419f38fdfd744ab3c75bc92
https://www.ajol.info/index.php/eamj/article/view/9428
https://www.ajol.info/index.php/eamj/article/view/9428
Autor:
J.B.O. Were, R. Muigai, L. Carpenter, Wasunna Km, J. A. Sherwood, K. P. W. J. Mcadam, G.S. Gachihi, J.G. Raynes
Publikováno v:
Transactions of the Royal Society of Tropical Medicine and Hygiene. 89(6)
Visceral leishmaniasis (VL) remains a major health problem in Kenya and other parts of Africa, Central America and Asia. Currently, splenic aspirate smear and culture are the standard methods of monitoring therapy and relapse. Acute phase reactant ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fe592440927069cca3a3b4a6ad7a9fb
https://pubmed.ncbi.nlm.nih.gov/8594695
https://pubmed.ncbi.nlm.nih.gov/8594695
Autor:
Thomas G. Brewer, C.N. Oster, K. U. Schaefer, D. R. Skillman, G.S. Gachihi, M. Mugo, L. L. Fleckenstein, Jonathan D. Berman, J. R. Rashid, G. Kirigi, Clifford R. Roberts, Wasunna Km, R. Muigai, B. G. Schuster, J.B.O. Were, J. Mbugua, Anthony J. Johnson, J. A. Sherwood, S. K. Kasili
Publikováno v:
Scopus-Elsevier
The efficacy of an oral 8-aminoquinoline (8-[[6-(diethylamino)hexyl]amino]-6-methoxy-4-methylquinoline) (WR6026) in the treatment of 16 patients with kala azar was evaluated. The first 8 patients received therapy for 2 weeks at a dosage of 0.75-1.00
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2b420ab25541a801734ef163edb8e51
https://pubmed.ncbi.nlm.nih.gov/7888530
https://pubmed.ncbi.nlm.nih.gov/7888530
Publikováno v:
Annals of tropical medicine and parasitology. 85(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7fe60e03bb6cb9a19c129d9993a9782
https://pubmed.ncbi.nlm.nih.gov/1746988
https://pubmed.ncbi.nlm.nih.gov/1746988
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
G. Gacmra, Chunge Cn, R. Muigai, C.N. Oster, J.D. Chulay, Gabriel Anabwani, Wasunna Km, A.D.M. Bryceson, J.R. Rashid
Publikováno v:
Transactions of the Royal Society of Tropical Medicine and Hygiene. 79(5)
Five patients with long-standing visceral leishmaniasis who were unresponsive to sodium stibogluconate, 20 mg antimony/kg body-weight once or twice daily, were treated for 14 to 54 days with a combination of sodium stibogluconate at the same dose plu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03c3d863e2fa05f4a97d97e9604f43ff
https://pubmed.ncbi.nlm.nih.gov/3006296
https://pubmed.ncbi.nlm.nih.gov/3006296